Specific course of COVID-19 associated pneumonia in the tuberculosis patient after pleuropneumonectomy
https://doi.org/10.21292/2075-1230-2022-100-5-7-12
Abstract
The article describes a clinical case of viral pneumonia associated with COVID-19 of the only lung, it developed in the patient 30 days after pleuropneumonectomy which was done to manage fibrous cavernous pulmonary tuberculosis. The favorable course of COVID-19 was due to its timely detection and initiation of treatment, and possibly, it was due to using anti-tuberculosis chemotherapy containing antibacterial drugs that prevented nosocomial infections.
About the Authors
E. M. ZhukovaRussian Federation
Elena M. Zhukova, Doctor of Medical Sciences, Leading Researcher
81a, Okhotskaya St., Novosibirsk, 630040
Phone: +7 (383) 203-78-25
Zh. A. Laushkina
Russian Federation
Zhanna A. Laushkina, Doctor of Medical Sciences, Head of Department for Applied Research
Novosibirsk
D. A. Skvortsov
Russian Federation
Dmitry A. Skvortsov, Candidate of Medical Sciences, Head of Pulmonary Tuberculosis Surgery Department
Novosibirsk
N. V. Stavitskaya
Russian Federation
Natalia V. Stavitskaya, Doctor of Medical Sciences, Director
Novosibirsk
References
1. Vremennye metodicheskie rekomendatsii. Profilaktika, diagnostika i lechenie novoy koronavirusnoy infektsii (COVID-19) Versiya 12. [Provisional guidelines on prevention, diagnostics and treatment of the new coronavirus infection (COVID-19). Version 12]. Approved by the Russian MoH as of 21.09.2021.
2. Vremennyye metodicheskiye rekomendatsii po okazaniyu protivotuberkuleznoy pomoshchi v usloviyakh pandemii novoy koronavirusnoy infektsii (COVID-19). [Provisional guidelines for tuberculosis care provision during the novel coronavirus disease (COVID-19) pandemic]. Approved by the Panel of the Russian Phthisiologists' Society and the Panel of Phthisiologists' Association as of 28.04.2020.
3. Klinicheskie rekomendatsii. Tuberkulez u vzroslykh. [Clinical guidelines on tuberculosis in adults]. 2020, (Epub.). Available at: http://cr.rosminzdrav.ru/#/recomend/943.
4. Nechaeva O.B. The state and prospects of TB control service in Russia during the COVID-19 pandemic. Tuberculosis and Lung Diseases, 2020, vol. 98, no. 12, pp. 7-19. (In Russ.) https://doi.org/10.21292/2075-1230-2020-98-12-7-19.
5. Hogan A.B., Jewell B., Sherrard-Smith E. et al. The potential impact of the COVID-19 epidemic on HIV, TB and malaria in low- and middle-income countries. Lancet Glob. Health, 2020, 8, e1132-е1141. https://doi:10.25561/78670.
6. Kumar R., Bhattacharya D.B., Meena D.V. et al. COVID-19 and TB coinfection-Finishing touch in perfect recipe to severity or death. J. Infection, 2020, vol. 81, no. 3, pp. e39-e40. doi:10.1016/j.jinf.2020.06.062.
7. Motta I., Centis R., D'Ambrosio L. et al. Tuberculosis, COVID-19 and migrants: preliminary analysis of deaths occurring in 69 patients from two cohorts. Pulmonology, 2020, no. 26, pp. 233-240 https://doi.org/10.1016/j.pulmoe.2020.05.002.
8. Rukmini S. How COVID-19 response disrupted health services in rural India. live MINT, 2020. Available: https://www.livemint.com/news/india/how-covid-19-response-disrupted-health-services-in-ruralindia-11587713155817.
9. Saunders M.J., Evans C.A. Tuberculosis and poverty: preventing a perfect storm. Eur. Respir. J., 2020, no. 56, 2001348. doi: 10.1183/13993003.01348-2020.
10. Saunders M.J., Wingfield T., Datta S. et al. A household-level score to predict the risk of tuberculosis among contacts of patients with tuberculosis: a derivation and external validation prospective cohort study. Lancet Infect Dis., 2020, no. 20, pp. 110-122. doi:10.1016/S1473-3099(19)30423-2.
Review
For citations:
Zhukova E.M., Laushkina Zh.A., Skvortsov D.A., Stavitskaya N.V. Specific course of COVID-19 associated pneumonia in the tuberculosis patient after pleuropneumonectomy. Tuberculosis and Lung Diseases. 2022;100(5):7-12. (In Russ.) https://doi.org/10.21292/2075-1230-2022-100-5-7-12